Understanding these drugs is crucial for patients, caregivers, and healthcare professionals.

Ready to get started? Click below to access our interactive guide.

New Alzheimer’s treatments with monoclonal antibody drugs (or ‘mab’ drugs in short) have been promising.

As the landscape of Alzheimer’s therapeutics evolves, understanding these drugs is increasingly important. Alzheimer’s anti-amyloid mab drugs work by preventing the buildup of amyloid plaques in the brain.

In this guide, you’ll learn about:

• What monoclonal antibodies are and how they aim to treat Alzheimer’s disease
• The current landscape of FDA-approved mab drugs for Alzheimer’s treatment
• The relationship between mab drugs and the risk of brain bleeds